The Jackson Laboratory, Northern Light Health and University of Maine are collaborating on the research.
Alzheimer’s disease
Free Alzheimer’s educational conference to be held in Portland next week
The Alzheimer’s Foundation of America is hosting the conference on June 11 at the Portland Regency.
Alzheimer’s advocate, 74, riding high after running Boston Marathon
Ralph Carmona, of Portland, who ran to raise awareness of the disease and the importance of federal research funds, finished in 4 hours, 14 minutes, 42 seconds and already is looking forward to running again next year.
Portland man, 74, turns first Boston Marathon into a race to save Alzheimer’s research
Ralph Carmona, a 74-year-old Portland man who has Alzheimer’s, says he is a living example of the value of medical research.
Sen. Collins helps usher another Alzheimer’s bill into law
The Building Our Largest Dementia Infrastructure for Alzheimer’s Reauthorization Act of 2024, which was signed into law Wednesday, renews and expands federal funding opportunities for dementia care and support.
New laws spearheaded by Sen. Susan Collins extend funding for Alzheimer’s
The effort builds on a 2011 initiative that helped lead to new treatments for the disease.
Alzheimer’s drug that can slow disease gets backing from FDA advisers
If it wins final approval, the drug, donanemab, would only be the second Alzheimer’s drug cleared in the U.S. that’s been shown to convincingly slow cognitive decline and memory problems due to Alzheimer’s.
Shadowing Trump’s attacks on mental fitness – his own father’s dementia
Donald Trump’s father’s condition also drove a wedge into his family, which fell into years of lawsuits that alleged in part that Donald Trump sought to take advantage of his father’s dementia to wrest control of the family estate.
Air pollution tied to signs of Alzheimer’s in brain tissue, study finds
A study published this week says the association holds for people who are not already genetically predisposed to Alzheimer’s.
Portland man takes part in drug trial giving new hope in fight against Alzheimer’s disease
Ralph Carmona participated in a clinical research trial for Leqembi, a new Alzheimer’s drug that he believes stopped his symptoms from progressing.